Immunotherapy: Programming Your Immune System to Target Cancer Cells

MUSC Health medical oncologist John M. Wrangle, M.D.,  and cancer immunologist  Mark P. Rubenstein, Ph.D., discuss the promise of immunotherapy  and their close collaboration that has led to a clinical trial of a novel combination immunotherapy for non-small cell lung cancer.

More at Progressnotes, MUSC’s Medical Magazine

 


Published

November 16, 2016

Created by

The Medical University of South Carolina

Related Presenters

John M. Wrangle, MD

John M. Wrangle, MD

Dr. John M. Wrangle is a board-certified medical oncologist. His clinical specialties include non-small cell lung cancer and small cell lung cancer. His medical degree was awarded by Tulane University School of Medicine. He completed a ...

View full profile

Mark P. Rubenstein, PhD

Mark P. Rubenstein, PhD

Assistant Professor of Surgery Ph.D. awarded from the Medical University of South Carolina - 2002 Postdoctoral Fellowships - Scripps Research Institute and University of California, San Diego - 2003-2008

View full profile